Zhejiang Dayang Biotech Group Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 714.74 million compared to CNY 735.17 million a year ago. Revenue was CNY 714.74 million compared to CNY 735.17 million a year ago.

Net income was CNY 40.18 million compared to CNY 50.1 million a year ago. Basic earnings per share from continuing operations was CNY 0.4857 compared to CNY 0.6 a year ago. Diluted earnings per share from continuing operations was CNY 0.4857 compared to CNY 0.6 a year ago.